We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | NYSE:PFE | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.09 | 0.32% | 27.79 | 27.905 | 27.52 | 27.86 | 60,534,542 | 23:09:07 |
From May 2019 to May 2024
By Cecilia Butini
The European Medicines Agency said Friday that its human medicines committee has adopted recommendations to increase manufacturing capacity and supply of Covid-19 vaccines in the European Union.
The agency said it has approved an increase in batch size and process scale-up at Pfizer Inc.'s manufacturing site in Puurs, Belgium, a move which is expected to have a "significant" impact on the supply of the vaccine it developed with BioNTech SE.
The agency's committee for medicinal products for human use also recommended the approval of a new filling line at Moderna Inc.'s manufacturing site in Rovi, Spain, the EMA said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
April 23, 2021 09:31 ET (13:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Pfizer Chart |
1 Month Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
